Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesMaintenance Dialysis
You have accessRestricted Access

Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes

Rachel Whitty, Joanne M. Bargman, Alex Kiss, Linda Dresser and Philip Lui
CJASN December 2017, 12 (12) 2016-2022; DOI: https://doi.org/10.2215/CJN.00630117
Rachel Whitty
*Laboratory Medicine Program,
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne M. Bargman
‡Department of Medicine,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Kiss
§Department of Research Design and Biostatistics, Sunnybrook Research Institute, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Dresser
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
‖Antimicrobial Stewardship Program, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Lui
†Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; and
¶Department of Pharmacy, University Health Network, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 12 (12)
Clinical Journal of the American Society of Nephrology
Vol. 12, Issue 12
December 07, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes
Rachel Whitty, Joanne M. Bargman, Alex Kiss, Linda Dresser, Philip Lui
CJASN Dec 2017, 12 (12) 2016-2022; DOI: 10.2215/CJN.00630117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Residual Kidney Function and Peritoneal Dialysis–Associated Peritonitis Treatment Outcomes
Rachel Whitty, Joanne M. Bargman, Alex Kiss, Linda Dresser, Philip Lui
CJASN Dec 2017, 12 (12) 2016-2022; DOI: 10.2215/CJN.00630117
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Association of Polypharmacy with Kidney Disease Progression in Adults with CKD
  • The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function
  • Collectin11 and Complement Activation in IgA Nephropathy
Show more Original Articles

Maintenance Dialysis

  • Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis
  • Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis
  • Association of Serum Phosphate with Efficacy of Statin Therapy in Hemodialysis Patients
Show more Maintenance Dialysis

Cited By...

  • Peritoneal dialysis-associated peritonitis caused by Enterococcus avium
  • Variability in Culture-Negative Peritonitis Rates in Pediatric Peritoneal Dialysis Programs in the United States
  • Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients
  • Peritoneal Dialysis-Associated Peritonitis
  • Chryseobacterium indologenes peritonitis in a peritoneal dialysis patient
  • Effective Treatment of PD Peritonitis
  • Google Scholar

Similar Articles

Related Articles

  • Effective Treatment of PD Peritonitis
  • PubMed
  • Google Scholar

Keywords

  • peritonitis
  • peritoneal dialysis
  • residual kidney function
  • antibiotic clearance
  • continuous cyclic peritoneal dialysis
  • continuous ambulatory peritoneal dialysis
  • Anti-Bacterial Agents
  • creatinine
  • Treatment Failure
  • treatment outcome
  • recurrence

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire